Heuristic design of cancer chemotherapies

IEEE Transactions on Evolutionary Computation

Volumn 8, Issue 6, 2004, Pages 513-521

  Villasana, Minaya ^a   Ochoa, Gabriela ^a  

^a UNIVERSIDAD SIMÓN BOLÍVAR   (Venezuela)

Author keywords

Cancer model; Cycle specific chemotherapy; Evolution strategies (ESs); Evolutionary algorithms (EAs); Genetic algorithms (GAs); Simulated annealing (SA); Singular optimal control

Indexed keywords

CELLS; CHEMOTHERAPY; EVOLUTIONARY ALGORITHMS; GENETIC ALGORITHMS; MATHEMATICAL MODELS; ONCOLOGY; OPTIMAL CONTROL SYSTEMS; OPTIMIZATION; SIMULATED ANNEALING; TUMORS;

CANCER CHEMOTHERAPIES; CANCER MODEL; CYCLE SPECIFIC CHEMOTHERAPY; EVOLUTION STRATEGIES (ESS); SINGULAR OPTIMAL CONTROL;

HEURISTIC METHODS;

EID: 11844275971     PISSN: 1089778X     EISSN: None     Source Type: Journal    
DOI: 10.1109/TEVC.2004.834154     Document Type: Article

References (29)

1. D. V. Arnold and H.-G. Beyer, "A comparison of evolution strategies with other direct search methods in the presence of noise," Comput. Opt. Applicat., vol. 1. no. 24. pp. 135-159, 2003.
2. Y. Biran and B. McInnis. "Optimal control of bilinear systems: Timevarying effects of cancer drugs," Automatica, vol. 15, pp. 325-329, 1979.
3. B. Birkhead, E. Rankin, S. Gallivan, L. Dones, and R. Rubens, "A mathematical model of the development of drug resistance to cancer chemotherapy," Eur. J. Cancer Clinical Oncology, vol. 23, no. 9. pp. 1421-1427, 1987.
4. A. Buldayev, "A numerical method of control optimization in delay systems for immune response modeling," U.S.S.R. Comput. Maths. Math. Phys., vol. 30, no. 5, pp. 18-28, 1990.
5. L. Chuang, E. Lotzova. K. Cook. P. Cristoforoni, M. Morris, and T. Wharton, "Effect of new investigational drug taxol on oncolytic activity and stimulation of human lymphocytes," Gynecologic Oncol. vol. 49. pp. 291-298, 1993.
6. L. Cojocaru and Z. Agur, "A theoretical analysis of interval drug dosing for cell-cycle-phase-specific drugs," Math. Biosci., vol. 109, pp. 85-97, 1992.
7. A. Corana, M. Marchesi, C. Martini, and S. Ridella, "Minimizing multimodal functions of continuous variables with the "simulated annealing," algorithm," in ACM Trans. Math. Softw., vol. 13. 1987, pp. 262-280.
8. L. de Pillis and A. Radunskaya, "A mathematical tumor model with immune resistance and drug therapy: An optimal control approach," J. Theor. Med., 2001
9. L. J. Fogel, A. J. Owens, and M. J. Walsh, Artificial Intelligence Through Simulated Evolution. New York: Wiley, 1966.
10. N. Hansen and A. Ostermeier, "Adapting arbitrary normal mutation distributions in evolution strategies: The covariance matrix adaptation," in Proc. 1996 IEEE Int. Conf. Evolutionary Computation Nagoya, Japan. 1996, pp. 312-317.
11. N. Hansen and A. Ostermeier, "Completely derandomized self-adaptation in evolution strategies," Evol. Comput., vol. 9, pp. 159-195, 2001.
12. J. Hardman and L. Linbird, Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw-Hill, 1996.
13. J. H. Holland, Adaptation in Natural-and Artificial Systems. Ann Arbor. MI: Univ. Michigan Press, 1975.
14. C. Houck, J. Joines, and M. Kay, "A genetic algorithm for function optimization: A Matlab implementation," North Carolina State Univ., Raleigh, NC, Tech. Rep. NCSU-IE TR 95-09, 1995.
15. M. Kamien and N. Schwartz, Dynamic Optimization, 2nd ed. Amsterdam, The Netherlands: North-Holland, 1991, vol. 31. Advanced textbooks in economics.
16. S. Kirkpatrick, C. D. Gelatt, and M. P. Vecchi, "Optimization by simulated annealing," Science, vol. 220, no. 4598, pp. 671-680, May 13, 1983.
17. R. Luus, Iterative Dynamic Programming, Monographs and Surveys in Pure and Applied Mathematics. London, U.K.: Chapman & Hall. 2000, vol. 110.
18. J. McCall and A. Petrovski, "A decision support system for cancer chemotherapy using genetic algorithms," in Proc. Int. Conf. Computational Intelligence for Modeling, Control, Automation, vol. 1. M. Mouhammadian, Ed., Vienna, Austria, 1999, pp. 65-70.
19. Z. Michalewicz, Genetic Algorithms + Data Structures = Evolution Programs. Berlin, Germany: Springer-Verlag, 1992.
20. Z. Michalewicz and B. F. Fogel, How to Solve it: Modern Heuristics Berlin, Germany: Springer-Verlag, 2000.
21. J. C. Panetta and J. Adam, "A mathematical model of cycle-specific chemotherapy," Math. Comput. Modeling, vol. 22. no. 2, pp. 67-82, 1995.
22. W. H. Press. B. P. Flannery, S. A. Teukolsky, and W. T. Vetterling, Numerical Recipes in C. Cambridge, U.K.: Cambridge Univ. Press, 1991.
23. I. Rechenberg, Evolution Strategy: Optimization of Technical Systems by Means of Biological Evolution. Stuttgart, Germany: Fromman-Holzboog, 1973.
24. A. Rundell, R. DeCarlos, V. Balakrishnan, and H. HogenEsch, " Systematic method for determining intravenous drug treatment strategies aiding the humoral immune response," IEEE Trans. Biomed. Eng., vol. 45, pp. 429-439, Apr. 1998.
25. J. Sear, "Clinics in anaesthesiology," in Intravenous Anaesthesiology. Philadelphia. PA: Saunders, 1984, vol. 2, ch. 12, p. 223.
26. L. F. Shampine and S. Thompson, Solving DDES with Matlab, http:// www.runet.edu/~thompson/webddes/index.html.
27. M. Villasana, "A delay differential equation model for tumor-immune system interactions," Ph.D. dissertation. Claremont Graduate Univ., Claremont, CA, 2001.
28. M. Villasana and A. Radunskaya, "A delay differential equation model for tumor growth," J. Math. Bio., vol. 47, pp. 270-294, 2003.
29. W. Zoli, A. Flamigni, G. Frassineti, P. Bajorko, F. De Paola, C. Milandri, D. Amadori, and A. Gasperi-Campani, "In vitro activitity of taxol and toxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers," Breast Cancer Res. Treatment, vol. 34, pp. 63-69. 1995.